The Fundação Champalimaud has officially opened the DNTx Centre, a new clinical facility dedicated to the treatment of strokes and neurodegenerative diseases. This project represents an investment of more than seven million euros, creating a space where traditional psychiatry and neurology are integrated with advanced digital tools.
A New Approach to Brain Recovery
The center operates on the fundamental principle that the human brain retains the ability to learn and adapt even after suffering a lesion. By utilizing targeted, repeated, and intense stimuli, the medical team aims to help patients compensate for motor and cognitive difficulties or recover functions that were previously lost.
To maximize the effectiveness of these treatments, the DNTx Centre employs five primary technological pillars designed to personalize care for each patient.
Bridging Research and Clinical Practice
The development of the project involved the collaboration of American neuroscientist John Krakauer from Johns Hopkins University. Clinical leadership of the center has been assigned to neurologist Marcelo Mendonça and psychiatrist Albino Oliveira-Maia.
These specialists are committed to establishing a direct communication cycle between medical practice and scientific research. This integrated approach is intended to accelerate the process of bringing new treatments to patients.
Future Implications for Neurotechnology
As part of the Foundation’s broader Neuroscience Program, the DNTx Centre may serve as a catalyst for further innovation in digital therapeutics. The synergy between the new clinic and the existing technological development laboratory could lead to more refined digital tools for brain rehabilitation.
the focus on brain plasticity suggests that future protocols may become increasingly personalized, potentially improving the quality of life for those living with severe cognitive or motor impairments.
Frequently Asked Questions
What is the primary focus of the DNTx Centre?
The center is a clinical hub focused on treating strokes (AVC) and neurodegenerative diseases by combining traditional neurology and psychiatry with advanced digital tools.
Who is responsible for the clinical direction of the center?
The clinical direction is led by psychiatrist Albino Oliveira-Maia and neurologist Marcelo Mendonça.
What is the core philosophy behind the treatments provided?
The center is based on the principle that the human brain can adapt and learn even when injured, using intense and directed stimuli to recover lost functions or compensate for difficulties.
How do you think the integration of digital tools will change the future of rehabilitation for brain injuries?
